Skip to content

Tyra Biosciences, Inc.

TYRA· NasdaqCore metricsCIK 1863127

Pharmaceutical preparations553 peers

Last sale
Nov 9, 2026 · +5.37%
Market cap
$1.54B
69.08M shares
Filings
428
—
—
—
-$51.12M
Q3 2026N/M FY25 yoy
-$54.89M
Q3 2026N/M FY25 yoy
-$96.10M
Q3 2026derivedN/M FY25 yoy
-$0.74
Q3 2026N/M FY25 yoy
$456.02M
Q3 2026−15.9% FY25 yoy
$1.54B
—
—
2.2×
-6.19%
—

FY2025 figures · derived

Price

$22.29+53.64%+$7.78past year
Nov 9, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$102.93MFY 2025
$102.93M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$102,928,000reported
FY 20242024-12-31$80,077,000reported
FY 20232023-12-31$62,518,000reported
FY 20222022-12-31$43,008,000reported
FY 20212021-12-31$20,636,000reported
FY 20202020-12-31$7,203,000reported

Pharmaceutical preparations

Tyra Biosciences, Inc. is the 115th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Tyra Biosciences, Inc. · CIK 1863127 · Engraved from SEC EDGAR